Literature DB >> 11879595

Acute Nonvariceal Upper Gastrointestinal Hemorrhage.

Grace H. Elta1.   

Abstract

Upper endoscopy to assess the risk of rebleeding in patients with nonvariceal upper gastrointestinal bleeding may be used for triage, allowing outpatient care of selected patients and leading to significant cost savings. Over the last 10 years, hospitalization days required for upper gastrointestinal bleeding have decreased significantly and the majority of patients with upper gastrointestinal bleeding undergo endoscopy within 24 hours of admission. Twenty percent to 35% of these endoscopies include endoscopic hemostatic therapy. Endoscopic treatment is recommended for actively bleeding (ie, spurting or oozing) visible vessels and nonbleeding visible vessels that are raised and cannot be washed off. Endoscopic methods can be divided into thermal (multipolar coagulation, heater probe, argon plasma coagulator, Nd:YAG laser) and nonthermal (eg, injection therapy); both types are effective. A combination of injection and thermal therapy with initial injection to slow the bleeding or "clear the field" followed by coagulation of the identified vessel is popular. Bleeding recurs in 15% of patients. A recent randomized controlled trial of repeat endoscopic treatment versus surgery for patients with recurrent ulcer bleeding concluded that endoscopic retreatment is superior to surgery. Most peptic ulcer rebleeding occurs within the first 3 days of presentation. A comparison of omeprazole and placebo therapy in high-risk ulcer patients with bleeding stigmata at endoscopy who were not treated endoscopically found that high-dosage omeprazole (40 mg twice a day) significantly lowered the rates of further bleeding and surgical intervention. Although unlikely to replace endoscopic therapy, this study demonstrated the efficacy of potent acid suppression, perhaps due to stabilization of clotting activity. A recent placebo-controlled trial of high-dosage parenteral omeprazole after endoscopic treatment of bleeding peptic ulcers demonstrated a substantial reduction in the risk of rebleeding.

Entities:  

Year:  2002        PMID: 11879595     DOI: 10.1007/s11938-002-0062-6

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  35 in total

Review 1.  Endoscopic risk factors for bleeding peptic ulcer.

Authors:  J H Johnston
Journal:  Gastrointest Endosc       Date:  1990 Sep-Oct       Impact factor: 9.427

2.  Comparison of the hemostatic efficacy of the endoscopic hemoclip method with hypertonic saline-epinephrine injection and a combination of the two for the management of bleeding peptic ulcers.

Authors:  I K Chung; J S Ham; H S Kim; S H Park; M H Lee; S J Kim
Journal:  Gastrointest Endosc       Date:  1999-01       Impact factor: 9.427

3.  Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding.

Authors:  A Lanas; E Bajador; P Serrano; J Fuentes; S Carreño; J Guardia; M Sanz; M Montoro; R Sáinz
Journal:  N Engl J Med       Date:  2000-09-21       Impact factor: 91.245

4.  Prospective evaluation of immediate versus delayed refeeding and prognostic value of endoscopy in patients with upper gastrointestinal hemorrhage.

Authors:  L Laine; H Cohen; J Brodhead; D Cantor; F Garcia; M Mosquera
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

5.  Care of patients with upper gastrointestinal hemorrhage in academic medical centers: a community-based comparison.

Authors:  G S Cooper; A Chak; D L Harper; M Pine; G E Rosenthal
Journal:  Gastroenterology       Date:  1996-08       Impact factor: 22.682

6.  Risk assessment after acute upper gastrointestinal haemorrhage.

Authors:  T A Rockall; R F Logan; H B Devlin; T C Northfield
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

7.  The visible vessel as an indicator of uncontrolled or recurrent gastrointestinal hemorrhage.

Authors:  W J Griffiths; D A Neumann; J D Welsh
Journal:  N Engl J Med       Date:  1979-06-21       Impact factor: 91.245

8.  Endoscopic injection to arrest peptic ulcer hemorrhage: a prospective, randomized controlled trial; preliminary results.

Authors:  H J Lin; C Y Chan; F Y Lee; Z C Huang; C H Lee; S D Lee
Journal:  Hepatogastroenterology       Date:  1991-08

9.  Injection or heat probe for bleeding ulcer.

Authors:  S C Chung; J W Leung; J Y Sung; K K Lo; A K Li
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

10.  A comparison of omeprazole and placebo for bleeding peptic ulcer.

Authors:  M S Khuroo; G N Yattoo; G Javid; B A Khan; A A Shah; G M Gulzar; J S Sodi
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

View more
  2 in total

Review 1.  Therapeutic endoscopy for acute upper gastrointestinal bleeding.

Authors:  Mitchell S Cappell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-03-09       Impact factor: 46.802

2.  Efficacy of ankaferd blood stopper application on non-variceal upper gastrointestinal bleeding.

Authors:  Gokhan Gungor; M Hakan Goktepe; Murat Biyik; Ilker Polat; Tuncer Tuna; Huseyin Ataseven; Ali Demir
Journal:  World J Gastrointest Endosc       Date:  2012-12-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.